Anika Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | 76.2% | 50.2% | 32.3% |
| FY2017 | 75.8% | 40.5% | 28.2% |
| FY2018 | 70.4% | 20.6% | 17.7% |
| FY2019 | 74.9% | 29.9% | 23.7% |
| FY2020 | 52.9% | -21.7% | -18.4% |
| FY2021 | 56.1% | 1.8% | 2.8% |
| FY2022 | 46.9% | 2.3% | -9.5% |
| FY2023 | 49.5% | 0.5% | -49.6% |
| FY2024 | 63.4% | -4.3% | -47.0% |
| FY2025 | 56.6% | -9.8% | -9.6% |